C Lanzillotta

First name:
C
Last name:
Lanzillotta
Lanzillotta, C., Di Domenico, F., Perluigi, M., & Butterfield, D. A. (2019). Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives. Cns Drugs, 33(10), 957-969. https://doi.org/10.1007/s40263-019-00658-8
View
Di Domenico, F., Tramutola, A., Barone, E., Lanzillotta, C., Defever, O., Arena, A., et al. (2019). Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome. Redox Biology, 23, 101162. https://doi.org/10.1016/j.redox.2019.101162
View
Sharma, N., Tramutola, A., Lanzillotta, C., Arena, A., Blarzino, C., Cassano, T., et al. (2019). Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease. Neurobiology Of Disease, 125, 176-189. https://doi.org/10.1016/j.nbd.2019.02.003
View
Tramutola, A., Lanzillotta, C., Barone, E., Arena, A., Zuliani, I., Mosca, L., et al. Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome. Translational Neurodegeneration, 7, 28. https://doi.org/10.1186/s40035-018-0133-9 (Original work published 2018)
View
Tramutola, A., Abate, G., Lanzillotta, C., Triani, F., Barone, E., Iavarone, F., et al. (2018). Protein nitration profile of CD3+ lymphocytes from Alzheimer disease patients: Novel hints on immunosenescence and biomarker detection.. Free Radical Biology & Medicine, 129, 430-439. https://doi.org/10.1016/j.freeradbiomed.2018.10.414
View
Tramutola, A., Sharma, N., Barone, E., Lanzillotta, C., Castellani, A., Iavarone, F., et al. (2018). Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease. Biochimica Et Biophysica Acta. Molecular Basis Of Disease, 1864(10), 3309-3321. https://doi.org/10.1016/j.bbadis.2018.07.017
View
Tramutola, A., Lanzillotta, C., Perluigi, M., & Butterfield, D. A. (2017). Oxidative stress, protein modification and Alzheimer disease. Brain Research Bulletin, 133, 88-96. https://doi.org/10.1016/j.brainresbull.2016.06.005
View
Tramutola, A., Pupo, G., Di Domenico, F., Barone, E., Arena, A., Lanzillotta, C., et al. Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype. Journal Of Alzheimer's Disease : Jad, 52(1), 359-371. https://doi.org/10.3233/JAD-151105 (Original work published 2016)
View
Tramutola, A., Lanzillotta, C., Di Domenico, F., Head, E., Butterfield, D. A., Perluigi, M., & Barone, E. (2020). Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome. Neurobiology Of Disease, 137, 104772. https://doi.org/10.1016/j.nbd.2020.104772
View
Lanzillotta, C., Zuliani, I., Tramutola, A., Barone, E., Blarzino, C., Caforio, M., et al. (2021). Chronic PERK induction promotes Alzheimer-like neuropathology in Down syndrome: Insights for therapeutic intervention. Progress In Neurobiology, 196, 101892. https://doi.org/10.1016/j.pneurobio.2020.101892
View